Yonhap KoreanKO
GC녹십자 헌터증후군 치료제 국내허가…"치료선택지 확대"
(서울=연합뉴스) 신선미 기자 = GC녹십자의 뇌실투여형 헌터증후군 치료제 '헌터라제아이씨브이주'가 식품의약품안전처에서 품목허가를 받았다.
🇰🇷 대한민국 / 한국어
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.